fashion -WSS

fashion

author：hotspot 2025-08-11 09:47:35 - browse：5

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight.

“But after everything I’ve been through, my body was just not having it,” she said. So she turned to Jody Dushay, an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. After much discussion, the two decided that Laurie should try using weight loss medication — specifically, Wegovy — so she could become eligible for the surgery.

Before long, they had to grapple with the shortage of GLP-1 medications. “Within the first two months she had a good response,” Jody said. But “then there was the first round of shortages. … It looks like, you know, we’re heading towards that finish line. And then, ‘Oh, sorry, you can’t get it anymore.’”

On the “First Opinion Podcast,” I spoke with Jody and Laurie about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems. Our conversation was based on Jody’s recent First Opinion essay, “How the Wegovy shortage is making life impossible for my patients — and for me.” We talked about the patient and provider perspective, the way stigma affects access to care, the ways weight loss medications are changing the medical system, and how the drug shortage is only part of the problem of access.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

focus

WSS

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Wearables generate powerful data but its not useful to doctors, yet

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Readers respond to H5N1 and livestock movements, and more

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Readout LOUD podcast: Live from STAT Breakthrough Summit West

leisure time

fashion

hotspot

Virginia high school admissions case could be legal follow

Venture capitalist Bob Kocher on the state of digital health

Activists slam private health insurers over coverage restrictions

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Anesthesiologist group: stop taking Ozempic before surgery

Big Tobacco's 'harm reduction': Is it for real, or a sham?

What does generative AI mean for health care? We asked experts

Solving academic medical centers' existential crisis

The cancer drug shortage isn’t new — and neither are the solutions

Anxious about a speech? A startup wants you to pop a minty cardiac drug

focus

Health tech investors get more selective as pandemic boom fades

STAT Readout Newsletter: Biotech news today

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Case highlights the risks of experimental stem cell therapy

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Venture capitalist Bob Kocher on the state of digital health

hotspot

focus

focus

Wikipedia